CCDC124

gene
On this page

Also known as Lso2oxs1

Summary

CCDC124 (coiled-coil domain containing 124, HGNC:25171) is a protein-coding gene on chromosome 19p13.11, encoding Coiled-coil domain-containing protein 124 (Q96CT7). Ribosome-binding protein involved in ribosome hibernation: associates with translationally inactive ribosomes and stabilizes the nonrotated conformation of the 80S ribosome, thereby promoting ribosome preservation and storage.

Enables RNA binding activity. Predicted to be involved in transcription by RNA polymerase II. Located in cytosol and plasma membrane.

Source: NCBI Gene 115098 — RefSeq curated summary.

At a glance

  • GWAS associations: 5
  • Clinical variants (ClinVar): 49 total
  • MANE Select transcript: NM_001136203

Identifiers

Gene identifiers

FieldValue
HGNC IDHGNC:25171
Approved symbolCCDC124
Namecoiled-coil domain containing 124
Location19p13.11
Locus typegene with protein product
StatusApproved
AliasesLso2, oxs1
Ensembl geneENSG00000007080
Ensembl biotypeprotein_coding
OMIM621286
Entrez115098

Gene structure

Transcript identifiers

Ensembl transcripts: 22 — 21 protein_coding, 1 retained_intron

ENST00000445755, ENST00000596123, ENST00000597436, ENST00000602080, ENST00000873323, ENST00000873324, ENST00000873325, ENST00000873326, ENST00000873327, ENST00000926054, ENST00000926055, ENST00000926056, ENST00000926057, ENST00000926058, ENST00000926059, ENST00000926060, ENST00000926061, ENST00000926062, ENST00000926063, ENST00000926064, ENST00000926065, ENST00000944720

RefSeq mRNA: 2 — MANE Select: NM_001136203 NM_001136203, NM_138442

CCDS: CCDS12369

Canonical transcript exons

ENST00000445755 — 5 exons

ExonStartEnd
ENSE000006899001794326117943375
ENSE000010562621794265617942845
ENSE000016586621793641017936579
ENSE000017659131793301517933048
ENSE000030355631794350817943985

Expression profiles

Bgee: expression breadth ubiquitous, 214 present calls, max score 97.45.

FANTOM5 (CAGE): breadth ubiquitous, TPM avg 34.4647 / max 209.8827, expressed in 1821 samples.

FANTOM5 promoters (2 alternative TSS)

Promoter IDTPM avgSamples expressed
17456332.56231821
1745641.90241081

Top tissues by expression

238 total, by Bgee expression score (0-100, higher = more expressed):

TissueAnatomy IDExpression scoreQuality
anterior cingulate cortexUBERON:000983597.45gold quality
gastrocnemiusUBERON:000138897.35gold quality
lower esophagus muscularis layerUBERON:003583397.27gold quality
lower esophagusUBERON:001347397.26gold quality
right frontal lobeUBERON:000281097.20gold quality
esophagogastric junction muscularis propriaUBERON:003584196.99gold quality
apex of heartUBERON:000209896.96gold quality
muscle layer of sigmoid colonUBERON:003580596.90gold quality
Brodmann (1909) area 9UBERON:001354096.88gold quality
right atrium auricular regionUBERON:000663196.78gold quality
left coronary arteryUBERON:000162696.77gold quality
lower esophagus mucosaUBERON:003583496.77gold quality
hindlimb stylopod muscleUBERON:000425296.76gold quality
prefrontal cortexUBERON:000045196.64gold quality
muscle of legUBERON:000138396.60gold quality
mucosa of transverse colonUBERON:000499196.51gold quality
popliteal arteryUBERON:000225096.50gold quality
tibial arteryUBERON:000761096.49gold quality
C1 segment of cervical spinal cordUBERON:000646996.47gold quality
ascending aortaUBERON:000149696.34gold quality
aortaUBERON:000094796.32gold quality
thoracic aortaUBERON:000151596.30gold quality
coronary arteryUBERON:000162196.15gold quality
amygdalaUBERON:000187696.10gold quality
right coronary arteryUBERON:000162596.08gold quality
skin of legUBERON:000151196.02gold quality
hypothalamusUBERON:000189895.90gold quality
mucosa of stomachUBERON:000119995.89gold quality
ectocervixUBERON:001224995.82gold quality
esophagusUBERON:000104395.79gold quality

Single-cell (SCXA)

Detected in 2 experiment(s), a significant marker in 1.

ExperimentMarker?Max mean expression
E-ANND-3yes9.17
E-MTAB-7303no492.84

Regulation

Is transcription factor: no

miRNA regulators (miRDB)

3 targeting CCDC124, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):

miRNAMax scoreAvg scoremiRNA target_count
HSA-MIR-138-5P98.4370.491292
HSA-MIR-366197.8367.30705
HSA-MIR-10398-5P97.1264.941051

Literature-anchored findings (GeneRIF, showing 5)

  • Ccdc124 is a novel factor operating both for proper progression of late cytokinetic stages in eukaryotes. (PMID:23894443)
  • Structure and function of yeast Lso2 and human CCDC124 bound to hibernating ribosomes. (PMID:32687489)
  • Coiled-coil domain-containing protein-124 (Ccdc124) is a novel RNA binding factor up-regulated in endometrial, ovarian, and urinary bladder cancers. (PMID:33896821)
  • Dimerization underlies the aggregation propensity of intrinsically disordered coiled-coil domain-containing 124. (PMID:34369007)
  • Live Cell Protein Imaging of Tandem Complemented-GFP11-Tagged Coiled-Coil Domain-Containing Protein-124 Identifies this Factor in G3BP1-Induced Stress-Granules. (PMID:39009911)

Cross-species orthologs

5 orthologs

OrganismSymbolGene ID
danio_rerioccdc124ENSDARG00000043502
mus_musculusCcdc124ENSMUSG00000007721
rattus_norvegicusCcdc124ENSRNOG00000018932
drosophila_melanogasterCG6013FBGN0038675
caenorhabditis_elegansY73E7A.1WBGENE00022268

Protein

Protein identifiers

Coiled-coil domain-containing protein 124Q96CT7 (reviewed: Q96CT7)

All UniProt accessions (2): Q96CT7, M0R2F5

UniProt curated annotations — full annotation on UniProt →

Function. Ribosome-binding protein involved in ribosome hibernation: associates with translationally inactive ribosomes and stabilizes the nonrotated conformation of the 80S ribosome, thereby promoting ribosome preservation and storage. Also required for proper progression of late cytokinetic stages.

Subunit / interactions. Associates with translationally inactive ribosomes in the nonrotated state. Interacts with RASGEF1B.

Subcellular location. Cytoplasm. Cytoskeleton. Microtubule organizing center. Centrosome. Midbody.

Tissue specificity. Ubiquitously expressed.

Similarity. Belongs to the CCDC124 family.

RefSeq proteins (2): NP_001129675, NP_612451 (=MANE)

Domains & families (InterPro)

IDNameType
IPR010422Ccdc124/Oxs1Family
IPR054414Ccdc124/Oxs1_CDomain

Pfam: PF06244

UniProt features (9 total): region of interest 2, compositionally biased region 2, modified residue 2, chain 1, coiled-coil region 1, sequence variant 1

Structure

Experimental structures (PDB)

7 structures.

PDBMethodResolution (Å)
8K2CELECTRON MICROSCOPY2.4
6ZM7ELECTRON MICROSCOPY2.7
9P9HELECTRON MICROSCOPY2.84
6Z6LELECTRON MICROSCOPY3
6ZMEELECTRON MICROSCOPY3
8XSYELECTRON MICROSCOPY3
9B0J

Predicted structure (AlphaFold)

ModelpLDDTFraction very-high
AF-Q96CT7-F180.590.33

Functional residue map

Curated UniProt residues grouped by drug-discovery relevance — catalytic, ligand-binding, modification, and mutation-validated positions. Source: UniProtKB sequence features.

Post-translational modifications (2): 141, 194

Function

Pathways and Gene Ontology

Reactome pathways

0 pathways

MSigDB gene sets: 85 (showing top): GOCC_MICROTUBULE_ORGANIZING_CENTER, GOCC_CENTROSOME, GOBP_CELL_DIVISION, GOCC_MIDBODY, chr19p13, GOMF_TRANSCRIPTION_COACTIVATOR_ACTIVITY, KRIGE_RESPONSE_TO_TOSEDOSTAT_6HR_DN, BRUINS_UVC_RESPONSE_EARLY_LATE, DELACROIX_RARG_BOUND_MEF, GOMF_TRANSCRIPTION_COREGULATOR_ACTIVITY, MYC_UP.V1_UP, CAMP_UP.V1_UP, GSE5503_MLN_DC_VS_SPLEEN_DC_ACTIVATED_ALLOGENIC_TCELL_DN, GSE14415_ACT_TCONV_VS_ACT_NATURAL_TREG_DN, GOMF_TRANSCRIPTION_REGULATOR_ACTIVITY

GO Biological Process (3): transcription by RNA polymerase II (GO:0006366), cell division (GO:0051301), positive regulation of DNA-templated transcription (GO:0045893)

GO Molecular Function (3): transcription coactivator activity (GO:0003713), RNA binding (GO:0003723), protein binding (GO:0005515)

GO Cellular Component (7): nucleus (GO:0005634), centrosome (GO:0005813), cytosol (GO:0005829), plasma membrane (GO:0005886), midbody (GO:0030496), cytoplasm (GO:0005737), cytoskeleton (GO:0005856)

GO top-level categories

Rollup of top GO terms by namespace:

CategoryTerms
cellular anatomical structure3
DNA-templated transcription2
cellular process1
regulation of DNA-templated transcription1
positive regulation of RNA biosynthetic process1
transcription coregulator activity1
positive regulation of DNA-templated transcription1
nucleic acid binding1
binding1
intracellular membrane-bounded organelle1
centriole1
microtubule organizing center1
cytoplasm1
membrane1
cell periphery1
intracellular anatomical structure1
intracellular membraneless organelle1

Protein interactions and networks

STRING

1381 interactions, top by confidence (×1000):

Protein AProtein BPartner UniProtScore
CCDC124C5orf34Q96MH7749
CCDC124HAAOP46952669
CCDC124COPS8Q99627665
CCDC124IFRD2Q12894508
CCDC124RDH12Q96NR8506
CCDC124SERBP1Q8NC51490
CCDC124C19orf53Q9UNZ5481
CCDC124PPIAL4DF5H284466
CCDC124EML3Q32P44459
CCDC124PIK3R5Q8WYR1449
CCDC124CCDC77Q9BR77441
CCDC124TRIM64BA6NI03434
CCDC124AURKAIP1Q9NWT8432
CCDC124P4HBP07237428
CCDC124EIF3JO75822426

IntAct

92 interactions, top by confidence:

ABTypeScore
NPM1CCDC124psi-mi:“MI:0403”(colocalization)0.650
CCDC124NPM1psi-mi:“MI:0914”(association)0.650
NPM1CCDC124psi-mi:“MI:0915”(physical association)0.650
ABCE1EIF3Hpsi-mi:“MI:0914”(association)0.530
CHLSNRPL14psi-mi:“MI:0914”(association)0.530
CCDC124MYH9psi-mi:“MI:0915”(physical association)0.400
CCDC124H1-1psi-mi:“MI:0915”(physical association)0.400
CCDC124H2BC9psi-mi:“MI:0915”(physical association)0.400
CD81HIP1Rpsi-mi:“MI:0914”(association)0.350
Rpl35RPS6psi-mi:“MI:0914”(association)0.350
Bcas2PEX10psi-mi:“MI:0914”(association)0.350
Pcgf1SCAMP3psi-mi:“MI:0914”(association)0.350
RPL10RPS6psi-mi:“MI:0914”(association)0.350
BCORHSPD1psi-mi:“MI:0914”(association)0.350
Srp72psi-mi:“MI:0914”(association)0.350
Rrbp1PIPSLpsi-mi:“MI:0914”(association)0.350
NOP56C12orf43psi-mi:“MI:0914”(association)0.350
XRCC3DERL1psi-mi:“MI:0914”(association)0.350
EMC2TBL2psi-mi:“MI:0914”(association)0.350
MMGT1DERL1psi-mi:“MI:0914”(association)0.350
Xpo1IFT56psi-mi:“MI:0914”(association)0.350
NPHNRNPABpsi-mi:“MI:0914”(association)0.350
BCAR1MYO1Cpsi-mi:“MI:0914”(association)0.350
DLDNFKBIEpsi-mi:“MI:0914”(association)0.350
MAPTMEX3Apsi-mi:“MI:0914”(association)0.350
MAPTC11orf98psi-mi:“MI:0914”(association)0.350
MAPTPOTEFpsi-mi:“MI:0914”(association)0.350

BioGRID (148): CCDC124 (Affinity Capture-MS), CCDC124 (Affinity Capture-MS), CCDC124 (Proximity Label-MS), CCDC124 (Proximity Label-MS), CCDC124 (Affinity Capture-MS), CCDC124 (Affinity Capture-MS), CCDC124 (Affinity Capture-MS), CCDC124 (Affinity Capture-MS), CCDC124 (Affinity Capture-MS), CCDC124 (Affinity Capture-MS), CCDC124 (Affinity Capture-MS), CCDC124 (Affinity Capture-MS), CCDC124 (Affinity Capture-MS), CCDC124 (Affinity Capture-MS), CCDC124 (Affinity Capture-MS)

ESM2 similar proteins: A5JSS4, B1MTI8, O88892, P02641, P06398, P09739, P0C0A9, P12620, P45378, P84101, P84102, Q05310, Q0UVD1, Q148I0, Q1E554, Q28HN4, Q28IN9, Q2KIT1, Q2TBR9, Q2TBV6, Q32P76, Q3E7B7, Q4I5Z5, Q5R5J3, Q5R6N0, Q5R7C4, Q5R8X8, Q5REM2, Q5ZHK9, Q68EY7, Q6DD17, Q6GNG8, Q6NVR5, Q6PHE8, Q75NG9, Q7SDA6, Q7ZY35, Q8MKI3, Q8NHG7, Q8R1F0

Diamond homologs: O94389, Q28HN4, Q2TBV6, Q54GW3, Q5R8X8, Q68EY7, Q6DD17, Q6PHE8, Q96CT7, Q9D8X2

SIGNOR signaling

0 interactions.

Enriched among interaction partners

Reactome pathways and GO biological processes over-represented among this gene’s 117 IntAct physical interaction partners (hypergeometric vs the genome-wide background, BH-FDR, gene-set size 15–500, ranked by fold). A functional readout of the neighbourhood — distinct from this gene’s own memberships above, and biased toward well-studied / hub proteins, so read it as themes rather than proof.

Reactome pathways:

PathwayPartnersFoldFDR
SRP-dependent cotranslational protein targeting to membrane1619.1×6e-14
PELO:HBS1L and ABCE1 dissociate a ribosome on a non-stop mRNA1217.9×2e-10
Formation of a pool of free 40S subunits1317.3×1e-10
Peptide chain elongation1116.6×3e-09
Viral mRNA Translation1116.6×3e-09
Selenocysteine synthesis1115.7×4e-09
Eukaryotic Translation Termination1115.7×4e-09
L13a-mediated translational silencing of Ceruloplasmin expression1315.6×2e-10

GO biological processes:

GO termPartnersFoldFDR
cytoplasmic translation1323.8×6e-12
translational initiation517.8×1e-03
ribosomal small subunit biogenesis715.8×8e-05
translation1313.2×7e-09
rRNA processing79.8×1e-03

Disease & clinical

Clinical variants and AI predictions

ClinVar

49 variants total. Per-class counts are floors (≥ shown; pagination cap):

ClassificationCount (floor)
Pathogenic0
Likely pathogenic0
Uncertain significance43
Likely benign0
Benign0

Top pathogenic / likely-pathogenic (0)

SpliceAI

863 predictions. Top by Δscore:

VariantEffectΔscore
19:17936408:A:AGacceptor_gain1.0000
19:17936409:G:GGacceptor_gain1.0000
19:17936409:GCCT:Gacceptor_gain1.0000
19:17936564:G:GTdonor_gain1.0000
19:17936580:G:GGdonor_gain1.0000
19:17942654:A:AGacceptor_gain1.0000
19:17942654:AGGAG:Aacceptor_gain1.0000
19:17942655:G:GTacceptor_gain1.0000
19:17942655:GGA:Gacceptor_gain1.0000
19:17942655:GGAGG:Gacceptor_gain1.0000
19:17942824:C:Gdonor_gain1.0000
19:17942829:G:GTdonor_gain1.0000
19:17942830:G:GTdonor_gain1.0000
19:17942830:G:Tdonor_gain1.0000
19:17942899:GACCT:Gdonor_gain1.0000
19:17943233:T:TAacceptor_gain1.0000
19:17943239:T:TAacceptor_gain1.0000
19:17943243:A:AGacceptor_gain1.0000
19:17943244:C:Gacceptor_gain1.0000
19:17943247:A:AGacceptor_gain1.0000
19:17943248:C:Gacceptor_gain1.0000
19:17943251:A:AGacceptor_gain1.0000
19:17943251:ACCC:Aacceptor_gain1.0000
19:17943252:C:Gacceptor_gain1.0000
19:17943254:C:CAacceptor_gain1.0000
19:17943256:CCCA:Cacceptor_loss1.0000
19:17943258:CA:Cacceptor_loss1.0000
19:17943259:A:ACacceptor_loss1.0000
19:17943259:A:AGacceptor_gain1.0000
19:17943259:AGCC:Aacceptor_gain1.0000

AlphaMissense

1461 scored. Top likely-pathogenic:

VariantProtein changeam_pathogenicity
19:17943630:T:CL196P0.999
19:17943653:T:AW204R0.999
19:17943653:T:CW204R0.999
19:17936453:G:CK11N0.998
19:17936453:G:TK11N0.998
19:17943359:G:CA150P0.998
19:17943598:A:CK185N0.998
19:17943598:A:TK185N0.998
19:17943655:G:CW204C0.998
19:17943655:G:TW204C0.998
19:17936575:G:CR52P0.997
19:17943360:C:AA150D0.997
19:17943363:T:AI151N0.997
19:17943569:T:CF176L0.997
19:17943571:T:AF176L0.997
19:17943571:T:GF176L0.997
19:17943642:T:CL200P0.997
19:17943654:G:CW204S0.997
19:17943673:C:AN210K0.997
19:17943673:C:GN210K0.997
19:17936447:C:AN9K0.996
19:17936447:C:GN9K0.996
19:17936451:A:GK11E0.996
19:17936464:C:AA15D0.996
19:17936469:G:CA17P0.996
19:17936535:T:AW39R0.996
19:17936535:T:CW39R0.996
19:17936537:G:CW39C0.996
19:17936537:G:TW39C0.996
19:17936574:C:AR52S0.996

dbSNP variants (sampled 300 via entrez): RS1000150866 (19:17933451 C>G,T), RS1000286032 (19:17939107 G>A), RS1000347128 (19:17943969 A>G), RS1000471513 (19:17934603 T>C), RS1000478939 (19:17943872 C>T), RS1000686330 (19:17942927 C>A,G), RS1001030424 (19:17938584 T>C), RS1001263430 (19:17935041 A>C), RS1001495123 (19:17940488 C>T), RS1001793598 (19:17938685 G>A,C), RS1001878351 (19:17934927 C>A,G,T), RS1002225188 (19:17932969 T>C), RS1002270708 (19:17933730 A>G), RS1002277506 (19:17933088 G>A,T), RS1002488638 (19:17941467 G>A)

Disease associations

OMIM: gene MIM:621286 | disease phenotypes:

GenCC curated gene-disease

Mondo (0):

Orphanet (0):

HPO phenotypes

0 total (0 of 0 shown, HPO-id order):

GWAS associations

5 associations (top):

StudyTraitp-value
GCST90002385_505High light scatter reticulocyte count6.000000e-13
GCST90002385_506High light scatter reticulocyte count3.000000e-11
GCST90002386_201High light scatter reticulocyte percentage of red cells4.000000e-11
GCST90002386_75High light scatter reticulocyte percentage of red cells1.000000e-12
GCST90002387_48Immature fraction of reticulocytes1.000000e-14

EFO canonical traits (1, from GWAS)

EFO IDTrait name
EFO:0007986reticulocyte count

Drugs & pharmacology

Drug and pharmacology data

Is drug target: no

PharmGKB: 1 entry (VIP=true, CPIC=false)

CTD chemical–gene interactions

24 total (human), top 24 by PubMed support.

ChemicalActions (top 5)PubMed papers
sodium arsenitedecreases expression, increases expression3
bisphenol Adecreases methylation, increases expression2
Caffeinedecreases phosphorylation, increases expression2
Valproic Acidincreases expression, increases methylation2
Particulate Matterincreases abundance, decreases expression, decreases reaction2
aristolochic acid Iincreases expression1
bisphenol Fincreases expression1
beauvericindecreases expression1
pyrogallol 1,3-dimethyl etheraffects cotreatment, decreases expression, affects localization, increases expression1
beta-lapachoneincreases expression1
di-n-butylphosphoric acidaffects expression1
K 7174decreases expression1
bisphenol Bincreases expression1
2-methyl-2H-pyrazole-3-carboxylic acid (2-methyl-4-o-tolylazophenyl)amidedecreases expression, decreases reaction1
bisphenol AFincreases expression1
Air Pollutantsdecreases expression, increases abundance1
Vehicle Emissionsdecreases expression, decreases reaction1
Furaldehydeincreases expression, affects cotreatment, decreases expression, affects localization1
Ivermectindecreases expression1
Ribonucleotidesaffects binding1
Smokedecreases expression1
Sodium Chlorideaffects localization, increases expression, affects cotreatment, decreases expression1
Dronabinolincreases expression1
Cyclosporineincreases expression1

Clinical trials (associated diseases)

0 trials via MONDO — disease-level, not drug-specific.

No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.